The DNA Methylation–Autophagy Axis: A Driver of MSC Fate Imbalance in Skeletal Aging and Osteoporosis
Biology · 24.01.2026 · 15 (3) · 218
DOI: 10.3390/biology15030218 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 24.01.2026. Verfasst von Gaojie Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang 332005, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Research Project of the Jiangxi Provincial Department of Education, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Age-related osteoporosis is driven in part by senescence-associated rewiring of bone marrow mesenchymal stem cells (MSCs) from osteogenic toward adipogenic fates. Accumulating evidence indicates that epigenetic drift and reduced autophagy are not isolated lesions but are mechanistically coupled through a bidirectional DNA methylation and autophagy axis. Here, we summarize how promoter hypermethylation of genes involved in autophagy and osteogenesis suppresses autophagic flux and osteoblast lineage transcriptional programs. Conversely, autophagy insufficiency reshapes the methylome by limiting methyl donor availability, most notably S-adenosylmethionine (SAM), and by reducing the turnover of key epigenetic regulators, including DNA methyltransferases (DNMTs), ten-eleven translocation (TET) dioxygenases, and histone deacetylases (HDACs). This self-reinforcing circuitry exacerbates mitochondrial dysfunction, oxidative stress, and inflammation driven by the senescence-associated secretory phenotype (SASP), thereby stabilizing adipogenic bias and progressively impairing marrow niche homeostasis and bone remodeling. We further discuss therapeutic strategies to restore balance within this axis, including selective modulation of epigenetic enzymes; activation of AMP-activated protein kinase (AMPK) and mechanistic target of rapamycin (mTOR) signaling with downstream engagement of Unc-51-like autophagy-activating kinase 1 (ULK1) and transcription factor EB (TFEB); targeting sirtuin pathways; mitochondria- and autophagy-supportive natural compounds; and bone-targeted delivery approaches or rational combination regimens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang 332005, China.
- College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, China.
Förderung
- Science and Technology Research Project of the Jiangxi Provincial Department of Education
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Song, G., Li, X., Xiong, J., & Cheng, L. (2026). The DNA Methylation–Autophagy Axis: A Driver of MSC Fate Imbalance in Skeletal Aging and Osteoporosis. Biology, 15(3), 218. https://doi.org/10.3390/biology15030218
Vancouver
Song G, Li X, Xiong J, Cheng L. The DNA Methylation–Autophagy Axis: A Driver of MSC Fate Imbalance in Skeletal Aging and Osteoporosis. Biology. 2026;15(3):218. doi:10.3390/biology15030218
BibTeX
@article{Song2026,
author = {Song, Gaojie and Li, Xingnuan and Xiong, Jianjun and Cheng, Lingling},
title = {The DNA Methylation–Autophagy Axis: A Driver of MSC Fate Imbalance in Skeletal Aging and Osteoporosis},
journal = {Biology},
year = {2026},
volume = {15},
number = {3},
pages = {218},
doi = {10.3390/biology15030218}
}
EUVIMED